Allergy/Immunology

  • A perspective on discussing COVID-19 vaccines: Efficacy and adverse effects
    Brian F. Mandell, MD
    Cleveland Clinic Journal of Medicine December 2021, 88 (12) 644-645; DOI: https://doi.org/10.3949/ccjm.88b.12021

    Physicians should be vigilant and open-minded regarding possible adverse reactions to the vaccines, and should take time to discuss the demonstrated efficacy of vaccines with patients.

  • COVID-19 vaccine-induced cellulitis and myositis
    Sathishkumar Ramalingam, MD, Harkesh Arora, MD, Susan Lewis, MD, Kulothungan Gunasekaran, MD, Maheswari Muruganandam, MD, Sivakumar Nagaraju, MD and Priyesh Padmanabhan, MD
    Cleveland Clinic Journal of Medicine December 2021, 88 (12) 648-650; DOI: https://doi.org/10.3949/ccjm.88a.21038

    The day after receiving the second dose of the mRNA vaccine, redness and pain developed at the injection site, eventually involving the whole left arm and shoulder.

  • Updated guidelines for immune thrombocytopenic purpura: Expanded management options
    Sherwin DeSouza, MD and Dana Angelini, MD
    Cleveland Clinic Journal of Medicine December 2021, 88 (12) 664-668; DOI: https://doi.org/10.3949/ccjm.88a.20201

    The aim is to help practitioners decide on inpatient vs outpatient management, thresholds for initiating treatment, and options for second-line treatment in adults.

  • Antibody-mediated autoimmune encephalitis: A practical approach
    Justin R. Abbatemarco, MD, Chen Yan, MD, Amy Kunchok, MBBS and Alexander Rae-Grant, MD, FAAN, FRCPC
    Cleveland Clinic Journal of Medicine August 2021, 88 (8) 459-471; DOI: https://doi.org/10.3949/ccjm.88a.20122

    Symptoms may include subacute, progressive neuropsychiatric symptoms with associated cognitive dysfunction, movement disorders, and autoimmune seizures.

  • Heightening awareness of blistering disorders
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine June 2021, 88 (6) 308-309; DOI: https://doi.org/10.3949/ccjm.88b.06021

    The spectrum of associated disorders ranges from annoying to life-threatening.

  • New bullous lesions in a 72-year-old woman
    Hadrian Mendoza, MD, Justin Goodwin, MS, Jeffrey Gehlhausen, MD, Ian Odell, MD, PhD, Jennifer McNiff, MD and Karthik Gnanapandithan, MD
    Cleveland Clinic Journal of Medicine June 2021, 88 (6) 319-324; DOI: https://doi.org/10.3949/ccjm.88a.20180

    Her history included psoriasis, chronic lower-extremity edema, and hypertension.

  • Vaccinating the unvaccinated adult
    Dillon Cason, MD and Paul Williams, MD, FACP
    Cleveland Clinic Journal of Medicine May 2021, 88 (5) 279-285; DOI: https://doi.org/10.3949/ccjm.88a.20046

    Numbers of unvaccinated children are on the rise, but when they grow up, some of them come in for care.

  • Awareness can prompt the search for clinical zebras
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine March 2021, 88 (3) 133-134; DOI: https://doi.org/10.3949/ccjm.88b.03021

    When do we look hard for uncommon causes of common symptoms?

  • A cutaneous clue to HIV infection
    Stephen Chan, MD and Paul Aronowitz, MD
    Cleveland Clinic Journal of Medicine March 2021, 88 (3) 145-146; DOI: https://doi.org/10.3949/ccjm.88a.20042

    A retired trucker presented with fever, cough, dyspnea, and a rash on his forehead.

  • Oral immunotherapy: The answer to peanut allergy?
    Rachel M. Whitsel, APRN, Jaclyn A. Bjelac, MD, Ahila Subramanian, MD, Alice E. W. Hoyt, MD and Sandra J. Hong, MD
    Cleveland Clinic Journal of Medicine February 2021, 88 (2) 104-109; DOI: https://doi.org/10.3949/ccjm.88a.20130

    Gradually increasing doses of the allergen induces tolerance.

Pages